Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $62.0B |
| FY2017, ended Dec 31, 2017 | $64.5B |
| FY2018, ended Dec 31, 2018 | $70.7B |
| FY2019, ended Dec 31, 2019 | $70.3B |
| FY2020, ended Dec 31, 2020 | $54.2B |
| FY2021, ended Dec 31, 2021 | $93.8B |
| FY2022, ended Dec 31, 2022 | $144B |
| FY2023, ended Dec 31, 2023 | $137B |
| FY2024, ended Dec 31, 2024 | $126B |
| FY2025, ended Dec 31, 2025 | $114B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $125B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $24.4B |
| FY2017, ended Dec 31, 2017 | $32.6B |
| FY2018, ended Dec 31, 2018 | $38.7B |
| FY2019, ended Dec 31, 2019 | $36.7B |
| FY2020, ended Dec 31, 2020 | $18.8B |
| FY2021, ended Dec 31, 2021 | $45.8B |
| FY2022, ended Dec 31, 2022 | $78.5B |
| FY2023, ended Dec 31, 2023 | $56.1B |
| FY2024, ended Dec 31, 2024 | $54.7B |
| FY2025, ended Dec 31, 2025 | $58.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $63.3B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$3.62B | −$466M |
| FY2017, ended Dec 31, 2017 | −$855M | $2.49B |
| FY2018, ended Dec 31, 2018 | $6.26B | $6.18B |
| FY2019, ended Dec 31, 2019 | $7.19B | $4.47B |
| FY2020, ended Dec 31, 2020 | −$2.70B | $87.0M |
| FY2021, ended Dec 31, 2021 | $8.08B | $11.7B |
| FY2022, ended Dec 31, 2022 | $18.7B | $18.2B |
| FY2023, ended Dec 31, 2023 | $11.0B | — |
| FY2024, ended Dec 31, 2024 | $9.24B | — |
| FY2025, ended Dec 31, 2025 | $7.99B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $9.28B | — |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.61B |
| FY2017, ended Dec 31, 2017 | $6.33B |
| FY2018, ended Dec 31, 2018 | $5.92B |
| FY2019, ended Dec 31, 2019 | $5.09B |
| FY2020, ended Dec 31, 2020 | $2.99B |
| FY2021, ended Dec 31, 2021 | $5.03B |
| FY2022, ended Dec 31, 2022 | $6.46B |
| FY2023, ended Dec 31, 2023 | $5.63B |
| FY2024, ended Dec 31, 2024 | $5.61B |
| FY2025, ended Dec 31, 2025 | $6.50B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.57B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $27.3B |
| FY2017, ended Dec 31, 2017 | $22.4B |
| FY2018, ended Dec 31, 2018 | $16.1B |
| FY2019, ended Dec 31, 2019 | $18.1B |
| FY2020, ended Dec 31, 2020 | $19.1B |
| FY2021, ended Dec 31, 2021 | $19.9B |
| FY2022, ended Dec 31, 2022 | $16.6B |
| FY2023, ended Dec 31, 2023 | $18.9B |
| FY2024, ended Dec 31, 2024 | $24.3B |
| FY2025, ended Dec 31, 2025 | $23.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $23.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 2.8% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.24B |
| FY2017, ended Dec 31, 2017 | 1.17B |
| FY2018, ended Dec 31, 2018 | 1.13B |
| FY2019, ended Dec 31, 2019 | 1.08B |
| FY2020, ended Dec 31, 2020 | 1.35B |
| FY2021, ended Dec 31, 2021 | 1.30B |
| FY2022, ended Dec 31, 2022 | 1.22B |
| FY2023, ended Dec 31, 2023 | 1.18B |
| FY2024, ended Dec 31, 2024 | 1.27B |
| FY2025, ended Dec 31, 2025 | 1.22B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.20B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $126M | $272M | −$63.0M | — |
| FY2017, ended Dec 31, 2017 | $3.00B | $227M | −$63.0M | — |
| FY2018, ended Dec 31, 2018 | $3.00B | $265M | $121M | — |
| FY2019, ended Dec 31, 2019 | $3.50B | $274M | −$30.0M | — |
| FY2020, ended Dec 31, 2020 | $892M | $159M | −$5.00M | — |
| FY2021, ended Dec 31, 2021 | $3.62B | $304M | $145M | $13.1B |
| FY2022, ended Dec 31, 2022 | $9.27B | $377M | $362M | — |
| FY2023, ended Dec 31, 2023 | $5.40B | $334M | −$52.0M | — |
| FY2024, ended Dec 31, 2024 | $5.46B | $268M | −$78.0M | — |
| FY2025, ended Dec 31, 2025 | $5.02B | $336M | −$100M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $5.30B | — | −$84.0M | — |
Valuation
At current price- Market Cap
- $178B
- P/E
- 19.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.8×
- Price / Book
- 2.7×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $63.3B
- Revenue Growth YoY
- 9.6%
- Revenue CAGR 3Y
- −9.1%
- Revenue CAGR 5Y
- 25.7%
- EPS Growth YoY
- 1.3%
- Net Income Growth YoY
- 1.1%
Profitability
Trailing 12 months- Gross Margin
- 62.0%
- Operating Margin
- —
- Net Margin
- 14.7%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 14.2%
Earnings
Trailing 12 months- Net Income
- $9.28B
- EPS (diluted)
- $7.56
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $6.57B
- Total Debt
- $23.3B
- Net Debt
- $16.7B
- Total Assets
- $124B
- Total Liabilities
- $58.9B
- Shareholders' Equity
- $65.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $21.9B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 2.3%
- Dividend / Share
- $3.36
- Beta (5Y)
- 0.24
Every ratio is calculated from the company’s reported figures.